Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in
N

Neuraxis Inc
AMEX:NRXS

Watchlist Manager
Neuraxis Inc
AMEX:NRXS
Watchlist
Price: 4.35 USD
Market Cap: $46.3m
Write Note Create Alert Ask AI

Relative Value

The Relative Value of one NRXS stock under the Base Case scenario is 2.16 USD. Compared to the current market price of 4.35 USD, Neuraxis Inc is Overvalued by 50%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

NRXS Relative Value
Base Case
2.16 USD
Overvaluation 50%
Relative Value
Price
N
Worst Case
Base Case
Best Case

Valuation Multiples

P/S
View Details
P/E
View Details
P/OCF
View Details
P/FCFE
View Details
P/B
View Details
EV/S
View Details
EV/GP
View Details
EV/EBITDA
View Details
EV/EBIT
View Details
EV/OCF
View Details
EV/FCFF
View Details
EV/IC
View Details

Multiples Across Competitors

NRXS Competitors Multiples
Neuraxis Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Neuraxis Inc
AMEX:NRXS
42.9m USD 13.3 -5.5 -5.2 -5.2
US
Abbott Laboratories
NYSE:ABT
192.7B USD 4.3 29.4 16.7 22.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
174.9B USD 17.5 61.6 47 56.9
US
Stryker Corp
NYSE:SYK
137B USD 5.4 41.4 21.1 25.5
IE
Medtronic PLC
NYSE:MDT
131.9B USD 3.8 27.4 15.3 22.2
US
Boston Scientific Corp
NYSE:BSX
111.2B USD 5.7 39.5 23.5 32
US
Becton Dickinson and Co
NYSE:BDX
59.9B USD 2.7 34.7 12.7 21.7
DE
Siemens Healthineers AG
XETRA:SHL
46.1B EUR 2 21.6 12 16.9
US
IDEXX Laboratories Inc
NASDAQ:IDXX
51.6B USD 11.9 48.2 34.4 38
US
Edwards Lifesciences Corp
NYSE:EW
45.7B USD 7.7 33 23.4 25.7
US
Resmed Inc
NYSE:RMD
39.6B USD 7.4 26.8 18.9 21
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
N
Neuraxis Inc
AMEX:NRXS
Average EV/EBITDA: 22.5
Negative Multiple: -5.2 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
16.7
9%
1.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
47
24%
2
US
Stryker Corp
NYSE:SYK
21.1
12%
1.8
IE
Medtronic PLC
NYSE:MDT
15.3
8%
1.9
US
Boston Scientific Corp
NYSE:BSX
23.5
22%
1.1
US
Becton Dickinson and Co
NYSE:BDX
12.7
8%
1.6
DE
Siemens Healthineers AG
XETRA:SHL
12
11%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
34.4
11%
3.1
US
Edwards Lifesciences Corp
NYSE:EW
23.4
13%
1.8
US
Resmed Inc
NYSE:RMD
18.9
11%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
N
Neuraxis Inc
AMEX:NRXS
Average EV/EBIT: 28.3
Negative Multiple: -5.2 		N/A N/A
US
Abbott Laboratories
NYSE:ABT
22.7
17%
1.3
US
Intuitive Surgical Inc
NASDAQ:ISRG
56.9
25%
2.3
US
Stryker Corp
NYSE:SYK
25.5
16%
1.6
IE
Medtronic PLC
NYSE:MDT
22.2
17%
1.3
US
Boston Scientific Corp
NYSE:BSX
32
32%
1
US
Becton Dickinson and Co
NYSE:BDX
21.7
21%
1
DE
Siemens Healthineers AG
XETRA:SHL
16.9
15%
1.1
US
IDEXX Laboratories Inc
NASDAQ:IDXX
38
11%
3.5
US
Edwards Lifesciences Corp
NYSE:EW
25.7
14%
1.8
US
Resmed Inc
NYSE:RMD
21
12%
1.8

See Also

Summary
NRXS intrinsic value, competitors valuation, and company profile.
DCF Valuation
NRXS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
NRXS stock valuation using valuation multiples.
Wall Street Estimates
NRXS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
NRXS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 316,200+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.